{Abacavir Sulfate (CAS 188062-50-2): A Comprehensive Review of the Compound
Abacavir sulfate, identified by CAS registry number 188062-50-2, represents a potent agent utilized primarily in the therapy of human immunodeficiency virus infection, often as part of a combination therapy plan . It functions as a nucleoside reverse transcriptase inhibitor, interfering with the virus's ability to multiply. Those receiving abacavir must undergo genetic testing for the HLA-B*57:01 allele due to the risk of a severe hypersensitivity event if administered to those who are positive . The formulation is typically administered orally, and its action relies upon consistent adherence to the indicated dosage.
```
Abarelix: A Deep Analysis of the Compound with Registry Number 183552-38-7
Abarelix, identified by its CAS Number 183552-38-7, represents a distinct molecule designed primarily for the management of benign prostatic hyperplasia (BPH). This complex drug functions as a specific gonadotropin-releasing hormone (GnRH) blocker , disrupting the usual hormonal feedback that regulates testosterone generation. Consequently, abarelix results in a significant decrease in testosterone amounts, largely alleviating the indications associated with BPH. Investigations have focused on its potential application in other hormone-sensitive states , though its use remains largely focused on BPH care.
```text
Abiraterone Acetate (CAS 154229-18-2): Properties and Applications
Abiraterone acetate, identified by the Chemical Abstracts Service registry number 154229-18-2, represents a significant therapeutic agent in oncology, particularly for metastatic prostate cancer. The chemical structure is that of a prodrug, indicating it requires metabolic conversion within the body to the active form, abiraterone. Physically its properties, abiraterone acetate exists as a white to off-white powder, exhibiting limited solubility in water but increased solubility in organic solvents like ethanol or dimethyl sulfoxide. This molecular formula is C26H30O3, and its molecular weight is approximately 402.51 g/mol. Mainly, abiraterone acetate functions as an inhibitor of CYP17A1, an enzyme crucial for androgen biosynthesis. This action reduces the production of testosterone in the testes, adrenal glands, and prostate cancer tissues themselves, consequently disrupting cancer cell growth.
```
CAS Spotlight: Examining (Abacavir) ’s Molecular Identity
Defining the precise molecular composition of Abacavir Sulfate is essential for guaranteeing safe effectiveness and individual safety . Chemists at CAS have undertaken a extensive website study utilizing sophisticated instrumental methods to verify the compound 's specific signature. This exploration incorporates examining key characteristics such as IR spectra , molecular analysis , and nuclear magnetic techniques, producing in a comprehensive report of this key medication compound .
Understanding Abarelix: An View of its CAS Identification Number and Significance
Grasping the nuances of therapeutic compound creation sometimes involves interpreting unique references. Abarelix, an GnRH blocker used in managing localized tumors , possesses an rule . Its CAS number, distinctly 135838-34-4, functions as the key identifier within the global registry listing chemical compounds . This identification enables researchers and physicians to precisely identify information related about the features, safety , and efficacy .
Abiraterone Acetate: Chemical Profile and Identification via CAS 154229-18-2
Abiraterone acetate, a crucial medicinal compound used in the handling of prostate tumors, presents a distinct chemical signature. Its identification is frequently confirmed through the Chemical Abstracts Service (CAS) registry number 154229-18-2, a unique reference for this specific substance. Chemically, it’s an acetate ester of abiraterone, possessing a molecular formula of C26H30O3 and a molecular bulk of approximately 402.51 g/mol. The CAS number serves as a reliable method for ensuring the correct substance is being utilized in research and clinical settings, preventing errors and confirming accurate findings. Further analysis, employing techniques like molecular spectrometry and nuclear magnetic imaging, supports this identification and clarifies its composition.